| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 269.048 | 314.258 | 389.522 | 460.549 | 509.919 | 617.465 | 662.626 | 761.971 | 951.436 | 1.070.086 |
| Total Income - EUR | 269.457 | 314.633 | 389.555 | 460.643 | 509.958 | 617.481 | 666.773 | 762.073 | 951.669 | 1.069.662 |
| Total Expenses - EUR | 258.710 | 290.359 | 339.017 | 393.441 | 432.391 | 507.011 | 567.527 | 649.183 | 849.804 | 954.301 |
| Gross Profit/Loss - EUR | 10.748 | 24.273 | 50.538 | 67.202 | 77.566 | 110.470 | 99.246 | 112.890 | 101.864 | 115.361 |
| Net Profit/Loss - EUR | 8.781 | 20.444 | 46.231 | 62.576 | 73.154 | 107.001 | 93.988 | 106.758 | 91.495 | 98.365 |
| Employees | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 |
Check the financial reports for the company - Amaris Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.203 | 3.076 | 2.864 | 2.606 | 1.647 | 11.592 | 24.644 | 25.631 | 41.258 | 34.193 |
| Current Assets | 87.511 | 108.552 | 149.783 | 174.880 | 195.945 | 227.877 | 210.324 | 239.458 | 324.118 | 355.336 |
| Inventories | 39.425 | 58.146 | 59.327 | 62.541 | 70.317 | 89.112 | 96.136 | 106.988 | 157.707 | 160.404 |
| Receivables | 14.915 | 7.526 | 25.024 | 42.271 | 32.901 | 39.340 | 43.426 | 52.736 | 77.683 | 86.946 |
| Cash | 33.171 | 42.881 | 65.431 | 70.069 | 92.727 | 99.426 | 70.762 | 79.734 | 88.728 | 107.986 |
| Shareholders Funds | 18.749 | 20.497 | 46.284 | 62.627 | 73.204 | 107.051 | 94.036 | 106.806 | 133.483 | 98.414 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 72.965 | 91.131 | 106.716 | 115.099 | 124.899 | 133.101 | 141.768 | 159.159 | 233.305 | 292.278 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Amaris Pharm Srl